574 related articles for article (PubMed ID: 12743001)
1. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
[TBL] [Abstract][Full Text] [Related]
2. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.
Benkusky NA; Weber CS; Scherman JA; Farrell EF; Hacker TA; John MC; Powers PA; Valdivia HH
Circ Res; 2007 Oct; 101(8):819-29. PubMed ID: 17717301
[TBL] [Abstract][Full Text] [Related]
3. Defective cardiac ryanodine receptor regulation during atrial fibrillation.
Vest JA; Wehrens XH; Reiken SR; Lehnart SE; Dobrev D; Chandra P; Danilo P; Ravens U; Rosen MR; Marks AR
Circulation; 2005 Apr; 111(16):2025-32. PubMed ID: 15851612
[TBL] [Abstract][Full Text] [Related]
4. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Okuda S; Yano M; Doi M; Oda T; Tokuhisa T; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Matsuzaki M
Circulation; 2004 Feb; 109(7):911-9. PubMed ID: 14757694
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6).
Xiao B; Sutherland C; Walsh MP; Chen SR
Circ Res; 2004 Mar; 94(4):487-95. PubMed ID: 14715536
[TBL] [Abstract][Full Text] [Related]
6. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death.
Marks AR
J Mol Cell Cardiol; 2001 Apr; 33(4):615-24. PubMed ID: 11273716
[TBL] [Abstract][Full Text] [Related]
7. Calstabin deficiency, ryanodine receptors, and sudden cardiac death.
Lehnart SE; Wehrens XH; Marks AR
Biochem Biophys Res Commun; 2004 Oct; 322(4):1267-79. PubMed ID: 15336974
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure.
Xiao B; Jiang MT; Zhao M; Yang D; Sutherland C; Lai FA; Walsh MP; Warltier DC; Cheng H; Chen SR
Circ Res; 2005 Apr; 96(8):847-55. PubMed ID: 15790957
[TBL] [Abstract][Full Text] [Related]
10. Cardiac ryanodine receptor function and regulation in heart disease.
Lehnart SE; Wehrens XH; Kushnir A; Marks AR
Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156
[TBL] [Abstract][Full Text] [Related]
11. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure.
Cheng Y; George I; Yi GH; Reiken S; Gu A; Tao YK; Muraskin J; Qin S; He KL; Hay I; Yu K; Oz MC; Burkhoff D; Holmes J; Wang J
J Pharmacol Exp Ther; 2007 May; 321(2):469-76. PubMed ID: 17277196
[TBL] [Abstract][Full Text] [Related]
12. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
13. beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure.
Reiken S; Gaburjakova M; Gaburjakova J; He Kl KL; Prieto A; Becker E; Yi Gh GH; Wang J; Burkhoff D; Marks AR
Circulation; 2001 Dec; 104(23):2843-8. PubMed ID: 11733405
[TBL] [Abstract][Full Text] [Related]
14. Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.
Phrommintikul A; Chattipakorn N
Int J Cardiol; 2006 Sep; 112(2):142-52. PubMed ID: 16701909
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular dysfunction after acute intracranial hypertension is associated with increased hydroxyl free radical production, cardiac ryanodine hyperphosphorylation, and troponin I degradation.
Hall SR; Wang L; Milne B; Hong M
J Heart Lung Transplant; 2005 Oct; 24(10):1639-49. PubMed ID: 16210142
[TBL] [Abstract][Full Text] [Related]
16. [Effect of carvedilol on ryanodine receptor in heart failure].
Li R; Yi QJ; Qian YR; Liu XY
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
[TBL] [Abstract][Full Text] [Related]
17. Maximum phosphorylation of the cardiac ryanodine receptor at serine-2809 by protein kinase a produces unique modifications to channel gating and conductance not observed at lower levels of phosphorylation.
Carter S; Colyer J; Sitsapesan R
Circ Res; 2006 Jun; 98(12):1506-13. PubMed ID: 16709901
[TBL] [Abstract][Full Text] [Related]
18. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
[TBL] [Abstract][Full Text] [Related]
19. Limitations of FKBP12.6-directed treatment strategies for maladaptive cardiac remodeling and heart failure.
Seidler T; Teucher N; Hellenkamp K; Unsöld B; Grebe C; Kramps P; Schotola H; Wagner S; Schöndube FA; Hasenfuss G; Maier LS
J Mol Cell Cardiol; 2011 Jan; 50(1):33-42. PubMed ID: 20797399
[TBL] [Abstract][Full Text] [Related]
20. Ryanodine receptors, FKBP12, and heart failure.
Marks AR
Front Biosci; 2002 Apr; 7():d970-7. PubMed ID: 11897558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
